Rapid Influenza Diagnostic Tests: Uses, Limits & Accuracy
This paper examines rapid influenza diagnostic tests (RIDTs) as point-of-care tools for detecting influenza A and B viral antigens in respiratory specimens. It reviews how RIDTs function, the sample types they use, and their formats. The paper also analyzes their clinical value — particularly during institutional disease outbreaks — alongside their limitations, including variable sensitivity, false negative results during peak influenza activity, and false positives during low-activity periods. Factors affecting RIDT performance, such as specimen collection timing, patient age, and collector training, are also discussed. The paper concludes that while RIDTs offer speed and convenience, clinicians must interpret results with caution, especially when more accurate alternatives such as RT-PCR are available.
- Introduction: Defines influenza and introduces RIDTs
- How RIDTs Work and Where They Are Used: RIDT mechanism, types, and outbreak applications
- Sample Types, Antigen Targets, and Test Formats: Specimen types, NP antigen targets, and test formats
- Specificity, Sensitivity, and the Risk of False Results: Performance metrics and false positive/negative risks
- Limitations as Clinical Decision-Making Tools: When RIDTs should not replace superior tests
- Conclusion: Balanced summary of RIDT benefits and limitations
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- It draws on authoritative sources — CDC, WHO, and peer-reviewed clinical literature — to anchor every major claim, giving the paper credibility despite its brevity.
- It presents a balanced evaluation: after establishing the utility of RIDTs, it methodically identifies their limitations, creating a logically complete argument.
- Direct quotations from WHO and CDC are used selectively to support precise technical claims about specificity ranges and result interpretation, rather than as padding.
Key academic technique demonstrated
The paper uses a classic advantages-and-limitations framework to evaluate a clinical diagnostic tool. By first establishing what RIDTs can do well — speed, ease of use, outbreak utility — and then systematically addressing their weaknesses, the paper models the kind of critical appraisal expected in health sciences writing. This approach avoids one-sided advocacy and demonstrates analytical balance.
Structure breakdown
The paper opens with a brief clinical definition of influenza before introducing RIDTs. The discussion section, which forms the bulk of the paper, moves from function and sample types to performance metrics and then to limitations. The conclusion synthesizes the trade-offs without introducing new information. This three-part introduction–discussion–conclusion structure is tight, well-suited to a short expository essay, and mirrors the format common in clinical review writing.
Introduction
Influenza is, in basic terms, a viral attack on the respiratory system. In most cases it is simply referred to as the flu. Some of the more common symptoms of influenza include — but are not limited to — a sore throat, nasal congestion, weakness and fatigue, headache, muscle aches, and fever. In terms of diagnosis, a physical exam is in most cases conducted alongside laboratory tests. There are various tests that can be used in influenza diagnosis, among them the rapid influenza diagnostic tests (RIDTs).
How RIDTs Work and Where They Are Used
According to the Centers for Disease Control and Prevention (CDC, 2016), RIDTs "are immunoassays that can identify the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens, and display the result in a qualitative way (positive vs. negative)." As the CDC further notes, these tests are commercially available in the United States. Examples of RIDTs include enzyme-linked immunosorbent assays and immunochromatographic tests. Due to their rapidity — that is, rapidly available results — and ease of use, RIDTs are in most instances deployed at the point of care.
During outbreaks of institutional respiratory diseases, RIDTs have proven valuable in identifying influenza. Thanks to RIDTs, authorities can act quickly to contain influenza — specifically by advancing prophylactic treatment to persons who, despite presenting no flu symptoms, have been exposed to the virus (Peci, Winter, King, Blair, & Gubbay, 2014). As Peci et al. (2014) further note, during outbreaks, RIDTs make it possible for "antivirals to be rapidly administered to patients" as one way of containing such outbreaks (p. 4310).
Sample Types, Antigen Targets, and Test Formats
There are various samples that can be utilized for RIDTs, including tracheal washings or aspirate, nasopharyngeal secretions, and other respiratory specimens. Specific optical signals — that is, color change — are used to indicate the presence of viral antigens (World Health Organization, 2018). According to the WHO, "the most common antigen target in commercially available pan-influenza, influenza A, influenza B, or combination influenza A and B tests is nucleoprotein (NP)" (WHO, 2018, p. 11). RIDTs are also available in various formats; those identified by the WHO include cards, cassettes, and dipsticks.
Specificity, Sensitivity, and the Risk of False Results
The specificity of RIDTs is generally high. For seasonal influenza, the WHO observes that specificity can range from 90 to 100 percent. On this point, "while false positive results can occur, they are uncommon when influenza viruses are circulating locally" (WHO, 2018, p. 15). Although the short turnaround time of RIDTs — typically under 15 minutes — is clinically convenient, the sensitivity of RIDTs when applied to respiratory specimens in an attempt to detect influenza viruses is limited. According to the CDC (2016), this limitation is especially apparent in comparison to viral culture or RT-PCR.
As a result, the CDC (2016) cautions that negative RIDT results should be "interpreted with caution given the potential for false negative results, especially during peak influenza activity in a community." It should also be noted that apart from false negatives, there is a significant probability of false positive results — particularly during periods of low influenza activity. Peci et al. (2014) identify a wide range of factors that influence both the specificity and sensitivity of RIDTs. These factors include "the influenza virus type and subtype, the body site from which the specimen was collected (e.g., nasopharyngeal versus throat swab), the time to specimen collection, and patient age" (Peci et al., 2014, p. 4312).
Conclusion
In summary, the utilization of RIDTs carries both advantages and disadvantages. In addition to being relatively simple to perform, the short turnaround time for results is largely relevant from a clinical perspective. However, as discussed above, these tests carry a significant potential to return false negative results — particularly during periods of high influenza activity. Thus, while RIDTs are beneficial and especially convenient for identifying influenza during institutional disease outbreaks, clinicians must remain aware of the limitations outlined here in order to promote their most effective use. For broader context on influenza and its clinical management, ongoing reference to updated CDC and WHO guidance is recommended.
References
Atkinson, K. & Mabey, D. (Eds.). (2019). Revolutionizing Tropical Medicine: Point-of-Care Tests, New Imaging Technologies and Digital Health. Hoboken, NJ: John Wiley & Sons.
Cantle, F., Thenabadu, S. & Lacy, C. (Eds.). (2015). Challenging Concepts in Emergency Medicine: Cases with Expert Commentary. New York, NY: Oxford University Press.
Centers for Disease Control and Prevention — CDC. (2016). Rapid influenza diagnostic tests. Retrieved from https://www.cdc.gov/flu/professionals/diagnosis/clinician_guidance_ridt.htm
Peci, A., Winter, A., King, E., Blair, J. & Gubbay, J. (2014). Performance of rapid influenza diagnostic testing in outbreak settings. Journal of Clinical Microbiology, 52(12), 4309–4317.
World Health Organization. (2018). Use of influenza rapid diagnostic tests. Retrieved from https://apps.who.int/iris/bitstream/handle/10665/44304/9789241599283_eng.pdf?sequence=1
Create your account
Always verify citation format against your institution’s current style guide requirements.